 compar trial agent treatment acut migrain headach studi object studi rel efficaci non-narcot agent chloropromazin lidocain dihydroergotamin treatment migrain headach emerg depart design trial singl set studi university-affili ed type particip patient isol diagnosi common classic migrain intervent patient mL IV normal salin random studi drug dihydroergotamin mg IV minut initi respons inadequ lidocain mg IV interv maximum total dose mg mg IV interv total maximum dose mg patient headach sever ten-point scale hour initi therapi phone follow day measur main result patient trial chloropromazin dihydroergotamin lidocain reduct mean headach intens chloropromazin persist headach relief chloropromazine-tr patient hour follow-up ten dihydroergotamine-tr patient lidocaine-tr group conclus rel effect antimigrain therapi chloropromazin measur headach relief incid headach rebound patient satisfact therapi